Adjuvant chemotherapy for gastric cancer or not: a dilemma?

J Natl Cancer Inst. 2008 Mar 19;100(6):376-7. doi: 10.1093/jnci/djn055. Epub 2008 Mar 11.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Biomarkers, Tumor / analysis*
  • Chemotherapy, Adjuvant
  • Cisplatin / administration & dosage
  • Disease-Free Survival
  • Epirubicin / administration & dosage
  • Fluorouracil / administration & dosage
  • Gastrectomy*
  • Humans
  • Italy
  • Leucovorin / administration & dosage
  • Randomized Controlled Trials as Topic
  • Stomach Neoplasms / chemistry
  • Stomach Neoplasms / drug therapy*
  • Stomach Neoplasms / pathology
  • Stomach Neoplasms / surgery
  • Treatment Outcome
  • United Kingdom

Substances

  • Biomarkers, Tumor
  • Epirubicin
  • Cisplatin
  • Leucovorin
  • Fluorouracil

Supplementary concepts

  • FLEP protocol